He was 70. Hinsche died on Saturday, Nov. 20, of giant cell carcinoma — the same day his 95-year-old mother Celia died in hospice, according to childhood friend Lucie Arnaz. "One of the finest ...

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (Romvimza) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue ...

Giant cell arteritis (GCA) is the most common form of vasculitis in the older adult population. There are variable clinical presentations of this entity and no perfect diagnostic test, often ...

Becoming the second drug approved by the U.S. FDA for tenosynovial giant cell tumors, Deciphera Pharmaceuticals Inc.’s oral CSF1R inhibitor vimseltinib, newly branded Romvimza, could take significant ...

for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue that lines the joints. Sarcoma oncologist William Tap, MD, Chief of the Sarcoma ...

for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue that lines the joints. Sarcoma oncologist William Tap, MD, Chief of the Sarcoma ...

Get Instant Summarized Text (Gist) The FDA has approved vimseltinib (Romvimza) for treating tenosynovial giant cell tumor (TGCT), a non-cancerous joint tissue tumor. In a Phase III trial, 67% of ...